Skip to main content

Table 2 TIGIT and CD226 expression on T cells of patients with DM and healthy controls

From: Expansion of circulating peripheral TIGIT+CD226+ CD4 T cells with enhanced effector functions in dermatomyositis

 

DM patients (n = 30)

Healthy controls (n = 26)

p value

CD4 T cell (percentages)

 TIGIT+CD226−%

6.995 ± 2.253

6.957 ± 1.871

p = 0.9459

 TIGIT+CD226+%

22.76 ± 7.063

18.87 ± 5.604

p = 0.0281

 TIGIT–CD226+%

20.96 ± 10.15

29.85 ± 7.492

P = 0.0005

 TIGIT–CD226−%

49.29 ± 16.41

43.17 ± 12.78

p = 0.1300

CD8 T cell (percentages)

 TIGIT+CD226−%

13.66 ± 7.037

10.52 ± 4.328

p = 0.0534

 TIGIT+CD226+%

35.26 ± 14.63

30.86 ± 10.45

p = 0.2085

 TIGIT–CD226+%

19.00 ± 13.61

20.75 ± 8.169

p = 0.5709

 TIGIT–CD226–%

32.07 ± 14.80

37.87 ± 14.59

p = 0.3003